- Home
- BNTX vs CBOE Comparison
BNTX vs CBOE Comparison
Compare BNTX & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- CBOE
- Stock Information
- Founded
- BNTX 2008
- CBOE 1973
- Country
- BNTX Germany
- CBOE United States
- Employees
- BNTX N/A
- CBOE N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- CBOE Investment Bankers/Brokers/Service
- Sector
- BNTX Health Care
- CBOE Finance
- Exchange
- BNTX Nasdaq
- CBOE Nasdaq
- Market Cap
- BNTX 26.4B
- CBOE 25.6B
- IPO Year
- BNTX 2019
- CBOE 2010
- Fundamental
- Price
- BNTX $104.27
- CBOE $247.92
- Analyst Decision
- BNTX Strong Buy
- CBOE Hold
- Analyst Count
- BNTX 14
- CBOE 13
- Target Price
- BNTX $138.99
- CBOE $238.77
- AVG Volume (30 Days)
- BNTX 633.2K
- CBOE 766.2K
- Earning Date
- BNTX 11-03-2025
- CBOE 10-31-2025
- Dividend Yield
- BNTX N/A
- CBOE 1.17%
- EPS Growth
- BNTX N/A
- CBOE 26.68
- EPS
- BNTX N/A
- CBOE 9.30
- Revenue
- BNTX $3,698,814,972.00
- CBOE $4,617,800,000.00
- Revenue This Year
- BNTX N/A
- CBOE N/A
- Revenue Next Year
- BNTX $9.49
- CBOE N/A
- P/E Ratio
- BNTX N/A
- CBOE $26.55
- Revenue Growth
- BNTX 3.70
- CBOE 16.74
- 52 Week Low
- BNTX $81.20
- CBOE $187.30
- 52 Week High
- BNTX $129.27
- CBOE $255.27
- Technical
- Relative Strength Index (RSI)
- BNTX 50.39
- CBOE 60.41
- Support Level
- BNTX $101.90
- CBOE $231.79
- Resistance Level
- BNTX $107.32
- CBOE $251.21
- Average True Range (ATR)
- BNTX 3.10
- CBOE 5.89
- MACD
- BNTX -0.19
- CBOE 0.86
- Stochastic Oscillator
- BNTX 35.56
- CBOE 83.20
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.